BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18438577)

  • 1. Analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinoma.
    Murta CB; Antunes AA; Dall'Oglio MF; Mosconi A; Leite KR; Srougi M
    Clinics (Sao Paulo); 2008 Apr; 63(2):223-8. PubMed ID: 18438577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for upper urinary tract urothelial carcinomas: stage, grade, and smoking status.
    Simsir A; Sarsik B; Cureklibatir I; Sen S; Gunaydin G; Cal C
    Int Urol Nephrol; 2011 Dec; 43(4):1039-45. PubMed ID: 21547471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.
    Thalmann GN; Markwalder R; Walter B; Studer UE
    J Urol; 2002 Oct; 168(4 Pt 1):1381-5. PubMed ID: 12352398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
    Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
    J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor.
    Palou J; Rodríguez-Rubio F; Huguet J; Segarra J; Ribal MJ; Alcaraz A; Villavicencio H
    J Urol; 2005 Sep; 174(3):859-61; discussion 861. PubMed ID: 16093970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.
    Cho MH; Kim SH; Park WS; Joung JY; Seo HK; Chung J; Lee KH
    World J Surg Oncol; 2016 Oct; 14(1):270. PubMed ID: 27765044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer after managing upper urinary tract transitional cell carcinoma: risk factors and survival.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Milenkovic-Petronic D; Vuksanovic A; Dragicevic D; Bumbasirevic U; Tulic C
    Int Urol Nephrol; 2011 Sep; 43(3):729-35. PubMed ID: 21350863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder tumor recurrence after primary surgery for transitional cell carcinoma of the upper urinary tract.
    Oehlschläger S; Baldauf A; Wiessner D; Gellrich J; Hakenberg OW; Wirth MP
    Urol Int; 2004; 73(3):209-11. PubMed ID: 15539838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary carcinoma of the renal pelvis and ureter. Evaluation of clinical and pathologic features.
    Strobel SL; Jasper WS; Gogate SA; Sharma HM
    Arch Pathol Lab Med; 1984 Sep; 108(9):697-700. PubMed ID: 6547821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma of the renal pelvis and ureter.
    Korkes F; Silveira TS; Castro MG; Cuck G; Fernandes RC; Perez MD
    Int Braz J Urol; 2006; 32(6):648-53; discussion 653-5. PubMed ID: 17201942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.
    Matin SF; Sfakianos JP; Espiritu PN; Coleman JA; Spiess PE
    J Urol; 2015 Dec; 194(6):1567-74. PubMed ID: 26094807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?
    Maulard-Durdux C; Dufour B; Hennequin C; Chrétien Y; Vignes B; Droz D; Delanian S; Housset M
    J Urol; 1996 Jan; 155(1):115-7. PubMed ID: 7490805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
    Aboumohamed AA; Krane LS; Hemal AK
    J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Yamashita R; Watanabe R; Ito I; Shinsaka H; Nakamura M; Matsuzaki M; Niwakawa M
    Int Urol Nephrol; 2017 Mar; 49(3):425-430. PubMed ID: 28078533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma.
    Zhang XK; Zhang ZL; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
    Jpn J Clin Oncol; 2015 Nov; 45(11):1069-75. PubMed ID: 26355163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic procedures in upper urinary tract urothelial carcinoma].
    Patschan O; Horstmann M; Thomas C; Schlemmer HP; Stenzl A
    Urologe A; 2008 Nov; 47(11):1487-96. PubMed ID: 19011832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomy.
    Colin P; Ghoneim TP; Nison L; Seisen T; Lechevallier E; Cathelineau X; Ouzzane A; Zerbib M; Long JA; Ruffion A; Crouzet S; Cussenot O; Audouin M; Irani J; Gardic S; Gres P; Audenet F; Roumiguié M; Valeri A; Rouprêt M
    World J Urol; 2014 Apr; 32(2):507-12. PubMed ID: 23812497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
    Akdogan B; Dogan HS; Eskicorapci SY; Sahin A; Erkan I; Ozen H
    J Urol; 2006 Jul; 176(1):48-52. PubMed ID: 16753365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.